The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)

Organizer: Kohei Tsuji (Science Tokyo), Hirokazu Tamamura (Science Tokyo), Shogo Misumi (Grad. Sch. Pharm. Sci., Kumamoto Univ.), Mikako Fujita (Fac. Life Sci., Kumamoto Univ.)

The symposium "Frontiers in studies on anti-viral infectious diseases -diverse approach toward drug development-", which has been held continuously since 2014, has covered variety of topics each time and has been a great success. In this year, the symposium is held under the theme of "diverse approach toward drug development." The COVID-19 pandemic has led to a renewed appreciation of the importance of basic research into viral infections. We will be introducing attractive approaches to drug discovery research from researchers with diverse research backgrounds such as pharmaceutical sciences, medicine, and virology. They will be presented their state-of-the-art approaches entitled "Medicinal chemistry on various inhibitors utilizing computational science" (TK), "Hijacking cellular metabolism modulates HIV-1 replication" (NK), "Establishment of a novel non-human primate model for infectious disease: Toward accelerating pharmaceutical development" (EU), "Discovery of chikungunya virus inhibitors by the reverse genetics approach" (YS), and "Advancing Antiviral Research Within Academic Constraints" (EK). As an interdisciplinary symposium, we hope that this symposium will promote multidisciplinary research collaborations.